DR REDDYS LAB
Location
South Carolina
Founded
2010-04-27
Website
Risk Signals
2 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Nonclassifiable Establishments), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DR REDDYS LAB
Live alerts from global media, monitored by Business Radar
2023-08-28 (financialexpress.com)
Pharma sector Q1 review: Growth led by US market, gRevlimid sales; India growth slips on price cuts, muted volumes
"Growth in domestic pharmaceutical revenues of all the major companies will be moderate. Lower RM prices and easing US generic pricing conditions will lead to higher gross and EBITDA margins. Net profits of the pharmaceutical companies are likely to grow 14 per cent in FY24 and 18 per cent in FY25."
Read more